Analysts Stocks

      Goldman Sachs raises AAL target to $15, stays Sell

      Goldman Sachs analyst Catherine O’Brien lifted their price target on AAL to $15 on July 2, rating held at Sell.

      Catherine has made 28 price-target calls on AAL that AnaChart has tracked. 18 of 28 were touched by the stock’s price at some point after the call.

      AAL carries 10 Buy, 5 Hold, 1 Sell ratings among the analysts AnaChart tracks. The target range spans James Goodall at Redburn ($12.5) to Christopher Stathoulopoulos at Susquehanna ($25). AAL last closed at $17.06.

      AAL price target chart: Goldman Sachs raises to $15
      AAL price targets: Catherine O’Brien against the highest and lowest current targets on the stock, plotted with the price.

      The $15 target is 12% below the stock’s $17.06 close.

      FAQ

      What is Goldman Sachs’s price target on AAL?

      Goldman Sachs’s Catherine O’Brien has a $15 target on AAL, rated Sell, set July 2, 2026.

      How often have Catherine O’Brien’s AAL price targets been reached?

      AnaChart has tracked 28 price-target calls from Catherine O’Brien on AAL; the stock reached the target in 18 of them (64%).

      What is the analyst view on AAL?

      Coverage is split 10 Buy / 5 Hold / 1 Sell, with targets from $12.5 (Redburn) to $25 (Susquehanna).